Cell Chem Biol. 2026 Mar 20:S2451-9456(26)00071-1.doi: 10.1016/j.chembiol.2026.03.001. (IF:7.2).

中文速读

针对KRAS G12V突变驱动的结直肠癌,使用SW620细胞皮下移植瘤裸鼠模型,通过Entranster-in vivo体内转染Pistol17及capped-Pistol17核酶,抑制肿瘤生长,capped-Pistol17组肿瘤抑制率达85%以上。

小鼠瘤内肿瘤SW620

本文使用:RNA体内转染Entranster™-in vivo

阅读完整中文解读 →

查看产品详情(含全部 503 篇文献) →

Engineered pistol ribozymes selectively target KRAS G12V with enhanced efficacy by capping modification

Affiliations

Affiliations

  • 1 State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, No. 38 Tongyan Road, Tianjin 300071, P.R. China; China Regional Research Centre, International Centre for Genetic Engineering and Biotechnology, 8 Taohongjing Road, Taizhou, Jiangsu 225316, P.R. China.
  • 2 State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, No. 38 Tongyan Road, Tianjin 300071, P.R. China.
  • 3 School of Medicine, University of St Andrews, North Haugh, St Andrews, Fife KY16 9TF, UK.
  • 4 China Regional Research Centre, International Centre for Genetic Engineering and Biotechnology, 8 Taohongjing Road, Taizhou, Jiangsu 225316, P.R. China.
  • 5 China Regional Research Centre, International Centre for Genetic Engineering and Biotechnology, 8 Taohongjing Road, Taizhou, Jiangsu 225316, P.R. China. Electronic address: yili.yang@icgeb.cn.
  • 6 State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, Frontiers Science Center for Cell Responses and College of Pharmacy, Nankai University, Haihe Education Park, No. 38 Tongyan Road, Tianjin 300071, P.R. China. Electronic address: yvliu@nankai.edu.cn.

Abstract

In this study, we rationally engineered a previously characterized pistol ribozyme to selectively target the KRAS p.G12V mutation with high specificity and efficiency. The pseudoknot-induced compact folding structure of the pistol ribozyme provides three-dimensional structural recognition of the KRAS substrate, distinguishing it from siRNA and ASO, which rely solely on primary sequence complementarity. This structural advantage enables the designed pistol ribozyme to effectively differentiate between KRAS wild-type and G12V mutant RNA. Furthermore, compared with 3′ end nucleotide derivative modifications, 5′ end capping is more effective at increasing ribozyme stability and compatibility with in vitro preparations. These features underscore the promising potential of natural pistol ribozymes as advanced therapeutic nucleic acid molecules for targeting KRAS mutation-driven cancers and suggest a generalizable strategy for structure-guided, allele-specific RNA therapeutics.

Keywords: KRAS mutation; catalysis; gene therapy; modification; pistol ribozyme.

阅读本文的中文解读 →

本文使用的产品

RNA体内转染Entranster™-in vivo

已有 503 篇已发表文献

查看产品详情(含全部 503 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单